Life Sciences/Animal Health and Research
The first doses of the Pfizer COVID-19 vaccine arrived in Kansas City on Monday morning. Officials with Truman Medical Centers and University Health said the first shipment of vaccine arrived Monday morning, and officials are now in the process of…
more
A panel of outside experts on Thursday recommended the issue an emergency use authorization to the Covid-19 vaccine being developed by Pfizer and BioNTech. The 17-4 vote came after members of the Vaccines and Related Biological Products Advisory Committee discussed…
more
Confirm BioSciences out of San Diego, Calif. has been acquired by Lenexa-based Clinical Reference Laboratory (CRL). CRL is one of the largest privately held clinical testing laboratories in the U.S., and now leverages Confirm's massive customer base in Drugs of…
more
AstraZeneca's COVID-19 vaccine was 70 percent effective at preventing infection from the virus in more than 11,000 participants in late-stage international trials, according to results published Dec. 8 in The Lancet. The vaccine was only about 60 percent effective among people…
more
Following the lead of Pfizer, Moderna will now be the second company to submit its COVID-19 vaccine for approval from the Food and Drug Administration (FDA). The Massachusetts-based biotechnology company has since finished its Phase 3 trials and said it…
more
Nearly $2 million in grant funding has been given to the University of Missouri-Kansas City for a study centered on COVID-19 testing in among minority populations in underserved communities. Through a National Institutes of Health (NIH) initiative, UMKC will receive $1.9…
more
Another COVID-19 vaccine, this time from multinational pharmaceutical and biopharmaceutical company AstraZeneca, is gaining attention for its positive late-stage trial results. Interim analysis of conducted trials show a 90 percent effective rate for the vaccine, according to trial data from…
more
Truman Medical Center/University Health has confirmed that's it among the first health care providers in the Kansas City area to administer bamlanivimab. Authorization for the drug was approved for those with a mild to moderate case of COVID-19 and aims…
more
Researchers at the University of Missouri-Columbia have received a boost of support from the National Aeronautic and Space Administration (NASA). An announcement Thursday revealed that NASA has given a team of researchers at the university a $5 million dollar grant…
more
The first emergency use authorization (EUA) for a COVID-19 treatment has been given to Eli Lilly by the U.S. Food and Drug Administration (FDA). Permission for emergency use was granted Monday for Lilly's COVID-19 antibody treatment called bamlanivimab. Authorization for…
more